Nuage-therapeutics

Discovery engine for small molecule modulators of disordered targets

Our science

Nuage Therapeutics mission is to leverage chemical biology and biomolecular condensation to develop selective drugs targeting proteins with disordered regions for challenging indications to improve patient’s life

Our team

Xavier Salvatella

Xavier Salvatella

Founder

Mateusz Biesaga

Mateusz Biesaga

Founder

Denes Hnisz

Denes Hnisz

Founder

Judit Anido

Judit Anido

Founder & CEO

Pilar Casado

Pilar Casado

Chief Financial Officer

Jordina Guillén

Jordina Guillén

Head of Science

Nadia Pons

Nadia Pons

Head of Corporate Development

Board of Directors

Clara Campàs

Clara Campàs

Board member

Xavier Salvatella

Xavier Salvatella

Board member

Denes Hnisz

Denes Hnisz

Board member

Judit Anido

Judit Anido

Board member

Nuage Therapeutics appoints biotech entrepreneur and executive Judit Anido as CEO

May 10, 2022

Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA is launched with the support of Asabys

September 28, 2021

Nuage Therapeutics appoints biotech entrepreneur and executive Judit Anido as CEO

May 10, 2022

Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA is launched with the support of Asabys

September 28, 2021

Private investors:

Project grants:

Careers

At the moment we do not have any vacancies, but we are always on the lookout for talent – please contact us through the “Get in touch” section

Get in touch

Address:
Parc Científic de Barcelona 
c/ Baldiri Reixac 4-8 (Torre D)
08028 Barcelona

8 + 9 =